1.Randomized Controlled Trial on "Cardiac Cycle: The First Step" Blinding the Students and the Rater
Yumiko ABE ; Janet DOMAN ; Daigo HAYASHI ; Nagisa KAMIOKA ; Manabu KOMORI ; Naoki MARUYAMA ; Kunio MIYAZAKI ; Kengo NOGUCHI ; Atsushi OHYA ; Naoyuki OKABE ; Hirotaka ONISHI ; Masato SHIBUYA ; Kazusa WADA ; Tomohiro YAMAMOTO
Medical Education 2004;35(1):17-23
“Cardiac Cycle: The First Step, ” which discretely, non-ambiguously, and accurately presents basic essential information on the cardiac cycle, was compared with conventional material in terms of educational efficiency. Twenty-six first-year medical students were randomly assigned to either material. The conventional group was presented with a standard textbook with a typical figure and text. The students were blinded as to the origin of the materials. After self-study, the same quiz (30 two-item choice questions asking basic essential information) was given to both groups and was scored by a blinded rater. The number of correct answers was 25.7±3.7 (mean±SD) in the conventional group and 29.4±1.1 in the ‘first-step group’(p<0.01).
2.A Case of Oxycodone-related Respiratory Depression Induced by Tumor Lysis Syndrome
Koji TERAMOTO ; Komaki HAYASHI ; Chiaki HASEGAWA ; Hiroaki MORII ; Yuri KIMURA ; Seiko HATTORI ; Sachiyo MORITA ; Hidetoshi SUMIMOTO ; Kazuya TERAMURA ; Yataro DAIGO
Palliative Care Research 2020;15(2):161-166
Tumor lysis syndrome (TLS) is a metabolic disorder that is caused by acute lysis of massive tumor cells. We report a case with opioids-related severe respiratory depression induced by TLS. A 39-year-old man received chemotherapy for mycosis fungoides. Two hours after administration of chemotherapeutic agents, his renal function worsened, and he was diagnosed with TLS by laboratory and clinical findings. Moreover, he showed severe respiratory depression and pinpoint pupils, and become drowsy. These symptoms were attributed to oxycodone that had been administered to treat his tumor-related cutaneous pain, and were improved by injection of anti-opioids agent naloxone. In this case, we consider that the clearance of oxycodone was disrupted by renal dysfunction caused by TLS, leading to enhancement of the effects of oxycodone.